BR112017022941A2 - dispositivo de neuromodulação - Google Patents

dispositivo de neuromodulação

Info

Publication number
BR112017022941A2
BR112017022941A2 BR112017022941-2A BR112017022941A BR112017022941A2 BR 112017022941 A2 BR112017022941 A2 BR 112017022941A2 BR 112017022941 A BR112017022941 A BR 112017022941A BR 112017022941 A2 BR112017022941 A2 BR 112017022941A2
Authority
BR
Brazil
Prior art keywords
methods
treating
signal
neuromodulation device
provides
Prior art date
Application number
BR112017022941-2A
Other languages
English (en)
Inventor
John Chew Daniel
Jacob De Jonge Wouter
Jakob Kristoffer Famm Hans
Patel Sonal
Welting Olaf
Original Assignee
Galvani Bioelectronics Limited
Academisch Medisch Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galvani Bioelectronics Limited, Academisch Medisch Centrum filed Critical Galvani Bioelectronics Limited
Publication of BR112017022941A2 publication Critical patent/BR112017022941A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A61N1/0556—Cuff electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36135—Control systems using physiological parameters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)

Abstract

a invenção apresenta aparelhos, sistemas e métodos para o tratamento e melhora de inflamação do intestino. em particular, a invenção apresenta dispositivos, aparelhos e métodos em que um sinal neuromodulador é distribuído a um nervo esplênico e/ou plexo mesentérico superior (smp). o sinal é capaz de tratar distúrbios inflamatórios, por exemplo, colite, por exemplo, em doença inflamatória intestinal.
BR112017022941-2A 2015-04-24 2016-04-22 dispositivo de neuromodulação BR112017022941A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562152119P 2015-04-24 2015-04-24
US62/152,119 2015-04-24
PCT/IB2016/052307 WO2016170510A1 (en) 2015-04-24 2016-04-22 Neuromodulation device

Publications (1)

Publication Number Publication Date
BR112017022941A2 true BR112017022941A2 (pt) 2018-07-17

Family

ID=55963419

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017022941-2A BR112017022941A2 (pt) 2015-04-24 2016-04-22 dispositivo de neuromodulação

Country Status (11)

Country Link
US (2) US10974041B2 (pt)
EP (2) EP3285856A1 (pt)
JP (1) JP2018514354A (pt)
KR (1) KR20180040516A (pt)
CN (1) CN108290041A (pt)
AU (1) AU2016252497A1 (pt)
BR (1) BR112017022941A2 (pt)
CA (1) CA2983652A1 (pt)
MA (1) MA41950A (pt)
RU (1) RU2017140776A (pt)
WO (1) WO2016170510A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180193643A1 (en) * 2015-06-05 2018-07-12 The Johns Hopkins University Method and device for sacral nerve stimulation
CN117258169A (zh) 2016-07-07 2023-12-22 加州大学评议会 使用超声波刺激组织的植入物
EP3727567A1 (en) 2017-12-20 2020-10-28 Galvani Bioelectronics Limited Treatment of inflammatory disorders
JP2021507750A (ja) 2017-12-20 2021-02-25 ガルバニ バイオエレクトロニクス リミテッド 急性疾患の治療
CN111787975B (zh) * 2017-12-20 2024-06-07 加尔瓦尼生物电子有限公司 供应脾脏的神经的刺激
EP3743157A1 (en) 2017-12-20 2020-12-02 Galvani Bioelectronics Limited Treatment of acute medical conditions
EP3727570A1 (en) * 2017-12-20 2020-10-28 Galvani Bioelectronics Limited Treatment of disorders associated with inflammation
KR20210016346A (ko) 2018-04-19 2021-02-15 아이오타 바이오사이언시즈 인코퍼레이티드 비장 신경 활동을 조절하기 위해 초음파 통신을 사용하는 이식물
US11033746B2 (en) 2018-04-19 2021-06-15 Iota Biosciences, Inc. Implants using ultrasonic communication for neural sensing and stimulation
CA3109810A1 (en) 2018-08-29 2020-03-05 Jose M. Carmena Implantable closed-loop neuromodulation device, systems, and methods of use
WO2020128790A1 (en) * 2018-12-20 2020-06-25 Galvani Bioelectronics Limited Neurostimulation device for blocking blood flow between electrodes
WO2020254793A1 (en) * 2019-06-19 2020-12-24 Galvani Bioelectronics Limited Treatment of acute medical conditions
WO2020254798A1 (en) * 2019-06-19 2020-12-24 Galvani Bioelectronics Limited Stimulation of a nerve supplying the spleen
US20220305259A1 (en) * 2019-06-19 2022-09-29 Galvani Bioelectronics Limited System for the Treatment of Disorders Associated with Inflammation
WO2022122833A1 (en) * 2020-12-09 2022-06-16 Galvani Bioelectronics Limited Physiological effects of activation of the alox15 pathway
CN113197587A (zh) * 2021-04-26 2021-08-03 中国科学院深圳先进技术研究院 一种用于迷走神经刺激和电生理检测的装置及植入方法
WO2023017253A1 (en) * 2021-08-10 2023-02-16 Galvani Bioelectronics Limited Neuromodulation device
KR20230078121A (ko) * 2021-11-26 2023-06-02 주식회사 뉴라이브 동물용 미주신경 자극장치
CN114177472A (zh) * 2021-11-30 2022-03-15 中国人民解放军总医院第四医学中心 一种应用于下肢假肢的植入式电刺激感知反馈系统

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2438541A1 (en) 2001-02-20 2002-08-29 Case Western Reserve University Systems and methods for reversibly blocking nerve activity
US20060116736A1 (en) * 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US20050075702A1 (en) 2003-10-01 2005-04-07 Medtronic, Inc. Device and method for inhibiting release of pro-inflammatory mediator
US7418292B2 (en) * 2003-10-01 2008-08-26 Medtronic, Inc. Device and method for attenuating an immune response
US8214047B2 (en) * 2004-09-27 2012-07-03 Advanced Neuromodulation Systems, Inc. Method of using spinal cord stimulation to treat gastrointestinal and/or eating disorders or conditions
AU2005323463B2 (en) * 2004-12-27 2009-11-19 The Feinstein Institutes For Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
EP1948301B8 (en) * 2005-11-10 2014-03-12 ElectroCore LLC Electrical stimulation treatment of bronchial constriction
JP2009525805A (ja) * 2006-02-10 2009-07-16 エレクトロコア、インコーポレイテッド 電気的変調を用いたアナフィラキシーの治療方法および治療装置
US9539425B2 (en) * 2006-10-13 2017-01-10 Intelect Medical, Inc. Systems and methods for treating medical conditions by stimulation of medial thalamic region
JPWO2008096730A1 (ja) * 2007-02-09 2010-05-20 国立大学法人名古屋大学 抗炎症剤及びその用途
US20090275997A1 (en) * 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
US20120172680A1 (en) * 2010-12-28 2012-07-05 G & L Consulting, Llc Method for sympathetic rebalancing of patient
WO2012154865A2 (en) * 2011-05-09 2012-11-15 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
ES2777177T3 (es) 2011-05-19 2020-08-04 Neuros Medical Inc Electrodo de manguito y generador para bloqueo eléctrico del nervio reversible
JP6441679B2 (ja) * 2011-12-09 2018-12-19 メタベンション インコーポレイテッド 肝臓系の治療的な神経調節
CN104145466A (zh) * 2012-02-24 2014-11-12 诺基亚公司 用于动态服务器/客户端控制的连通性逻辑的方法和装置
US11013549B2 (en) * 2012-03-08 2021-05-25 Medtronic Ardian Luxembourg S.A.R.L. Gastrointestinal neuromodulation and associated systems and methods
WO2014153223A1 (en) * 2013-03-14 2014-09-25 Perryman Laura Tyler Treating inflammation, chronic pain and other disorders with neuromodulation

Also Published As

Publication number Publication date
US20210393949A1 (en) 2021-12-23
AU2016252497A1 (en) 2017-11-09
MA41950A (fr) 2018-02-28
US10974041B2 (en) 2021-04-13
WO2016170510A1 (en) 2016-10-27
CN108290041A (zh) 2018-07-17
EP3950049A1 (en) 2022-02-09
CA2983652A1 (en) 2016-10-27
KR20180040516A (ko) 2018-04-20
EP3285856A1 (en) 2018-02-28
JP2018514354A (ja) 2018-06-07
US20180117319A1 (en) 2018-05-03
RU2017140776A (ru) 2019-05-24

Similar Documents

Publication Publication Date Title
BR112017022941A2 (pt) dispositivo de neuromodulação
IL281566A (en) Methods and systems for diagnosing and treating diseases
HK1252823A1 (zh) 用於治療性鼻神經調節的裝置及相關的方法和系統
BR112017007767A2 (pt) canabidiol para uso, método para tratar um paciente que sofre de complexo esclerose tuberosa, e, composição.
BR112017013022A2 (pt) métodos para tratar uma doença inflamatória e/ou autoimune aguda num mamífero que a necessite onde a terapia de corticosteróides é utilizada como terapia de primeira ou segunda linha e/ou para tratar uma doença inflamatória e/ou autoimune num mamífero que a necessite, onde a terapia de corticosteróides é utilizada como terapia de manutenção de primeira ou segunda linha e/ou para eliminar ou reduzir dose terapêutica de corticosteróides utilizado no tratamento de uma doença inflamatória e/ou autoimune num mamífero que a necessite, onde a terapia de corticosteróides é utilizada como terapia de manutenção crônica de primeira ou segunda linha e/ou de tratamento de uma doença autoimune e/ou inflamatória num mamífero que a necessite
BR112017006664A2 (pt) terapias de combinação
EP3288635A4 (en) SYSTEMS AND METHODS FOR TARGETED UVB LIGHT THERAPY AGAINST AUTOIMMUNE DISEASES AND OTHER INDICATIONS
BR112017003163A2 (pt) dispositivo de infraestrutura modular, sistema de infraestrutura e processo para operação de um dispositivo de infraestrutura
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
BR112018012130A2 (pt) dispostivo de processamento de dados, e método para a verificação da integridade de um dispositivo de processamento de dados tendo uma pluralidade de componentes de hardware
CL2016001076A1 (es) (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.
PL3157531T3 (pl) Sposoby i kompozycje do stymulacji jelitowego układu enteroendokrynnego w leczeniu chorób lub stanów związanych z tym układem
TN2017000074A1 (en) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
PH12019500422A1 (en) Methods and composition for the prediction of the activity of enzastaurin
BR112018000707A2 (pt) ?composições terapêuticas e produto de combinação?
GB2561300B (en) Method and system for diagnosing disease and generating treatment recommendations
EP3166477A4 (en) Systems and methods for diagnosis and treatment of swallowing disorders
BR112017026803A2 (pt) adaptador ou sistema adaptador para tornar dispositivos médicos funcionalmente estéreis
MX2017004723A (es) Composicion farmaceutica para usarse en el tratamiento o la prevencion de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugia de derivacion gastrica.
EP3506899A4 (en) COMPOSITION AND METHOD FOR DIAGNOSIS AND TREATMENT OF DISEASES OF THE LYMPHATIC SYSTEM
IT201700096334A1 (it) Sistema di stimolazione elettromeccanico per il trattamento del disturbo da tinnitus
FR3027826B1 (fr) Systeme et procede de traitement local de surface
IL242323B (en) Device, system, and method for the treatment of liquid waste waters
FR3045568B1 (fr) Dispositif de degivrage, installation de degivrage et procede de configuration d'une installation de degivrage
FR3042420B1 (fr) Dispositif de traitement par phototherapie

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]